Telomerase Complex from Yeast Saccharomyces cerevisiae Contains a Biotinylated Component by Shcherbakova, D.M. et al.
reSeArcH ArtIcLeS
 № 2 2009  | ActA nAturAe | 81
Telomerase Complex from Yeast 
Saccharomyces cerevisiae 
Contains a Biotinylated 
Component
D.M. Shcherbakova, M.I. Zvereva,* and O.A. Dontsova
Department of Chemistry, Moscow State University 
*E-mail: zvereva@genebee.msu.su
ABSTRACT telomerase adds telomeric repeats to single-stranded DnA at the ends of the chromosomes. this enzyme is a ribonucleoprotein complex. telomerase 
from yeast Saccharomyces cerevisiae consists of tLc1 rnA, which serves as a template for the synthesis of telomeric repeats, telomerase reverse transcriptase 
est2p, and a number of accessory proteins (est1p, est3p, Ku70/Ku80, and Sm-complex). We found that the yeast telomerase complex contains a biotinylated 
component. the telomerase fraction containing biotinylated protein is active in vitro and constitutes a small part of the total amount of active telomerase isolated 
from cells. We speculate about the nature of the biotinylated component.
Keywords: yeast telomerase, biotin, biotinylation.
Abbreviations: DeAe-fraction –  telomerase isolated from yeast extract using chromatography on DeAe-cellulose 
INTRODuCTION
telomeres are located at the ends of eukaryotic chromo-
somes. these DnA-protein structures protect chromosomes 
from degradation and end-to-end fusion [1]. telomerase is 
the enzyme that maintains the length of telomeres by adding 
telomeric DnA repeats to the 3′-ends of chromosomal DnA 
[2]. telomerase is active in the cells of organisms able to un-
limitedly propagate, in 85% of cancers [3], and in cells of uni-
cellular eukariotes (ciliates and yeasts) [2, 4].
telomerase is a ribonucleoprotein complex [5, 6]. In yeast 
Saccharomyces cerevisiae, telomerase is composed of telom-
erase reverse transcriptase est2p [7]; telomerase rnA tLc1 
[8], a region of which serves as a template for telomeric re-
peats synthesis; accessory proteins est1p [9] and est3p [10] 
(without which telomerase is inactive in vivo) [11]; and sev-
eral other proteins (Sm-proteins [12], Ku-proteins [13], etc.). 
Other than subunits of the telomerase complex, there are 
several proteins that interact with telomerase and contribute 
to telomerase functioning. For example, cdc13p, which teth-
ers telomerase to telomere and is crucial for its activity, is 
not a subunit of telomerase, although it interacts with est1p 
[14]. currently, a large number of genes whose absence leads 
to telomere shortening are known [15]. Some proteins (e.g., 
chaperone Hsp82p [16]) have also been shown to interact with 
subunits of the telomerase complex. Such proteins are prob-
ably important for complex assembly or form a transient part 
of telomerase on a particular step of regulation.  therefore, 
the sophisticated arrangement of telomerase is related to the 
complex regulation of its activity. It is known that telomere 
elongation occurs during the late S phase of the cell cycle [17, 
18], and telomerase preferentially extends the shortest telo-
meric ends [19–21]. Also, regulation may occur at the assem-
bly stage of the telomerase complex and the degradation of 
its components. revealing new interactions between various 
proteins and telomerase subunits, post-translational modifi-
cations of proteins important for telomerase activity, and the 
elucidation of its roles will lead us to a better understanding 
of how telomerase functions in a cell.
We found that an active telomerase complex contains a 
biotinylated compound. Such telomerase complexes comprise 
less than half of the total amount of telomerase isolated from 
cells.
MATERIALS AND METhODS
STRAINS Strain DBY-746 α (ura3-52, leu2-3,112, trp1-289, 
his3-Δ1) was used.
TELOMERASE PuRIFICATION uSINg STREPTAVIDI-BASED AF-
FINITY ChROMATOgRAPhY  the cell culture was grown to 
A600 = 1 in 3.2 liters of a Sc –  trp medium supplemented 
with glucose. cells were harvested by centrifugation (5 min, 
5,000 rpm, 4°c, JA-10 rotor; Beckman, uSA); washed four 
times with water; and, finally, washed with a “str” buffer 
(20 mM tris-Hcl, pH 7.5, 100 mM nacl, 2 mM Mgcl2, 1 mM 
dithiothreitol (Dtt), 0.1 mM eDtA, 10% (v/v) glycerol, 0.1% 
(v/v) triton X-100). the cell pellet was mechanically dis-
rupted in liquid nitrogen and thawed on ice with 10 ml of an 
ice-cold “str” buffer supplied with “complete protease in-
hibitor” (roche, Switzerland), phenylmethylsulfonyl fluoride 
(0.5 mM), and rnasin (40 u/ml of extract) (Helicon, russia). 
the cell debris was removed by centrifugation (once at 5 min, 
5,000 g and twice at 15 min, 15,000 rpm; 4°c, JA-20 rotor, 
Beckman, uSA). An aliquot of the extract was used to mea-
sure the total protein concentration using the compat-Able 82 | ActA nAturAe |  № 2 2009
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Protein Assay Kit and BcA Protein Assay reagent (Pierce 
Biotechnology, uSA). During the experiment, the extract 
was pretreated with avidin: 10 μg of avidin per 1 mg of total 
protein was added, and the sample was incubated for 10 min 
at 4°c. then, the yeast extract (10 mg/ml total protein) was 
added to a streptavidin-sepharose resin preequilibrated with 
a “str” buffer (200 μl of resin from Ge Healthcare (uSA) for 
10 ml of extract). the mixture was incubated at 4°c for 1.5 h 
under agitation. then, the resin was washed six times with a 
“str” buffer. the resin that was obtained and all other frac-
tions were frozen in liquid nitrogen and stored at – 80°c for 
further analysis.
TELOMERASE PuRIFICATION uSINg DEAE-BASED ANIONIC 
ChROMATOgRAPhY Yeast telomerase was prepared accord-
ing to [4, 22] with a slight modification: the telomerase frac-
tion was obtained by elution from a DeAe-cellulose column 
with a linear gradient concentration of sodium acetate (from 
100 mM to 1 M). From 10 ml of the initial extract (10 mg/ml 
total protein), 1ml of the active telomerase fraction was ob-
tained. then it was aliquoted, frozen in liquid nitrogen, and 
stored at – 80°c for further analysis.
FRACTIONATION OF S100 ExTRACT AND DEAE-FRACTION IN 
A gLYCEROL DENSITY gRADIENT the yeast extract was pre-
pared as described above for the isolation of telomerase using 
chromatography on straptavidin-sepharose, except that the 
YPD medium was used for cell growth and a lysis buffer (25 
mM tris-Hcl (pH 7.5), 300 mM naOAc, 2 mM Mgcl2, 1 mM 
Dtt, 0,1 mM eDtA, 10% (v/v) glycerol) was used instead 
of a “str” buffer. then, the S100 extract was obtained by the 
ultracentrifugation of the yeast extract (1h, 100,000g, 4°c, 
ti-70 rotor; Beckman, uSA). then, it was concentrated on a 
Vivaspin 20 (Sartorius, Germany). the S100 extract (0.5 ml, 
15 mg/ml total protein) or DeAe-fraction (0.5 ml) was loaded 
onto a 15–40% glycerol gradient (10.5 ml, in a lysis buffer). 
ultracentrifugation was performed at the following condi-
tions: 24h, 40,000rpm, 4°c, SW41 rotor; Beckman. twenty-
two fractions (0.5 ml each) were gathered, frozen in liquid 
nitrogen, and stored at – 80°c for further analysis.
IN VITRO TELOMERASE ASSAY ten microliters of the sample 
(obtained after isolating the streptevidin-sepharose suspen-
sion, DeAe-fraction, or the fraction obtained by ultracentrif-
ugation) was used in the elongation reaction. the final reac-
tion mixture (20 μl) contained 50 mM tris-Hcl (pH 8.0), 5 mM 
Mgcl2, 1 mM Dtt, 1 mM spermidine, 0.05 mM eDtA (con-
tributed by telomerase fraction), 5% (v/v) glycerol or more 
for the sample obtained in ultracentrifugation (contributed 
by telomerase fraction), 100 μM dttP, 20 μci [α-32P]dGtP 
(3000 ci/mmol), and 5 μM oligodeoxyribonucleotide teL11 
(5′-tGGtGtGtGGG-3′). control reactions were pretreated 
with rnase A (1 μl of 10 mg/ml solution, 30 min, 30°c). the 
telomerase reaction was carried out for 1 h at 30°c followed 
by the addition of 200 μl of a “stop” buffer (20 mM tris_Hcl, 
pH 8.0, 20 mM eDtA, 0.2% SDS) and 3 μl proteinase K (20 
mg/ml). After incubation at 30°c for 1 h, the reaction prod-
ucts were extracted twice with equal volumes of phenol, once 
with an equal volume of chloroform–isoamyl alcohol (24 : 1), 
and precipitated with 3 volumes of ethanol in the presence 
of 1/10 volume of 3 M naOAc and 5 μg of trnA from E. coli 
as a carrier. the pellet was washed twice with 80% ethanol, 
dried and dissolved in the formamide loading buffer (80% of 
deionized formamide, 1 × tBe buffer, 0.1% xylene cyanole, 
and 0.1% bromophenol blue). reaction products, along with 
5′-[32P]-phosphorylated oligodeoxyribonucleotide teL11 as 
a length marker, were separated electrophoretically in 15% 
tBe denaturing PAAG. the gel was dried and analyzed using 
the PhosphorImager system (Molecular Dynamics, uSA). 
WESTERN BLOTTINg DETECTION OF BIOTINYLATED PROTEINS 
In the samples obtained after ultracentrifugation, the pro-
teins were precipitated by the slow addition of 5 volumes of 
ice-cold acetone and incubation of the mixture for 24 h at – 
20°c. the pellet was washed with ice-cold acetone, dried, dis-
solved in a buffer containing 8M urea and 70 mM tris-Hcl 
(pH 7.5), and diluted in water. Protein mixtures were separat-
ed by electrophoresis in 15% SDS-PAGe according to Laemmli 
[23]. Proteins from extract and DeAe-fraction were sepa-
rated in 10–12% SDS-PAGe without the precipitation step. 
they were transferred to nitrocellulose (Ge Healthcare) or 
PVDF (Biorad) membranes. to detect biotinylated proteins, 
streptavidin-HrP conjugate [24] and ecL kit (Ge Health-
care) were used.
RT-PCR ANALYSIS rnA for rt-Pcr was obtained using phe-
nol extraction, chloroform–isoamyl alcohol (24 : 1) extraction, 
and ethanol precipitation in the presence of 1/10 volume 3 
M naOAc and trnA from Escherichia coli as a carrier (5 μg 
per probe). Samples containing rnA bound to the strepta-
vidin-sepharose resin were pretreated with proteinase K as 
described above for telomerase assay in vitro. All the samples 
were treated with Dnase I (1 u/μg nucleic acids or 1 u/100 
μl fraction obtained by ultracentrifugation, 1 h at 37°c). Af-
ter that, rnA was purified from proteins with the use of ex-
traction and precipitation as described above. All the samples 
were diluted in an equal amount of water (usually 10 μl), 
and rnA concentration was measured spectrophotometri-
cally at 260 nm. the volume of the initial extract containing 
0.1–0.5 μg rnA was used for rt-Pcr analysis. An equal vol-
ume of unbound fraction and corresponding volume of bound 
fraction corrected for tLc1 concentration in binding from 
the extract were taken for rt-Pcr analysis. If fractions ob-
tained by ultracentrifugation were analyzed, 1 μl of the sam-
ple was used for analysis. For rt-Pcr reactions, a OneStep 
rt-Pcr Kit (Qiagen) was used. the gene-specific primers for 
tLc1 were P2 (5′-GtttAttctAGttttttccG-3′) and t8 
(5′-cGAAGGcAttAGGAGAAG-3′). rt-Pcr products were 
analyzed by electrophoresis in 2% agarose gel with a tBe buf-
fer (89 mM tris, 89 mM boric acid, 2 mM eDtA, pH 8.3).
RESuLTS AND DISCuSSION
ThE ACTIVE YEAST TELOMERASE COMPLEx CONTAINS BIOTI-
NYLATED PROTEIN It is known that yeast telomerase activity 
cannot be detected directly in the yeast extract obtained by 
the disruption of yeast cells. this becomes possible only after 
the step of enriching the telomerase complex by specifically 
binding the complex subunits on affinity resin (est1 [25], es-
t2p [26], est3p [10]) or by enriching the whole complex using 
anion-exchange chromatography [4, 22]. We found that when 
the yeast extract was bound to streptavidin-sepharose, active 
telomerase could be detected on the resin (Fig. 1a). this fact 
indicates that active telomerase is concentrated on affinity 
resin because there is no activity in the initial extract. the pat-
tern of detected activity is the same as the pattern of activity reSeArcH ArtIcLeS
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of telomerase isolated via the anion-exchange chromatogra-
phy on DeAe-cellulose and corresponds to the addition of one 
telomeric repeat in the in vitro reaction (Fig. 1a). 
to test if the binding of telomerase with streptavidin-Sep-
harose results from the “biotin-streptavidin” interaction (dis-
sociation constant Kd= 10-14 М [27]), we performed the binding 
experiment with the pretreatment of the yeast extract with 
avidin. Adding avidin is a common way to prevent binding 
with the streptavisin-sepharose of biotinylated proteins from 
the yeast extract [28], because the “biotin-avidin” interac-
tion (dissociation constant Kd= 10-15 М [29]) completely blocks 
the “biotin-sreptavidin” interaction. In fact, adding avidin 
prevents the binding of telomerase with the affinity resin 
(Fig. 1b). this result indicates that the interaction is specific. 
telomerase binding to the resin and the prevention of this 
binding by adding avidin were also shown for tLc1 rnA by 
rt-Pcr analysis (Fig. 1c).
In the next step, we performed the binding of telomerase 
that had already been purified via chromatography on De-
Ae-cellulose with the affinity resin. We found that active te-
lomerase in fact binds with streptavidin-sepharose, but only 
partially (Fig. 1d). this could be due to the fact that only part 
of telomerase complexes contains biotinylated protein. Also, 
we could not exclude the possibility that, during purification 
on DeAe-cellulose, some active telomerase complexes lose 
their biotinylated component.
ThE BIOTINYLATED PROTEIN-TELOMERASE SuBuNIT hAS AN 
APPARENT MASS OF 50 kDa AND IT IS A CONSTITuENT OF ONLY 
PART OF ThE TOTAL AMOuNT OF ACTIVE TELOMERASE We 
fractionated the yeast S100 extract as well as telomerase pu-
rified on DeAe-cellulose in a glycerol density gradient using 
ultracentrifugation. centrifugation of both types of samples 
was done simultaneously and under the same conditions. It is 
known that yeast telomerase sediments as 19S when ultra-
centrifugated [30]. We tested the obtained fractions for the 
presence of tLc1 rnA, telomerase activity, and biotinylat-
ed proteins (Figs. 2, 3). the distribution of active telomerase 
throughout the fractions is shown on Figs. 2a and 2c, and the 
distribution of tLc1 rnA is shown on Figs. 2b and 2d..
We used Western blotting for the detection of biotinylated 
proteins in the initial yeast extract (Fig. 3a) and initial DeAe-
fraction (Fig. 3b), as well as the distribution of biotinylated 
proteins throughout the fractions obtained by ultracentrifu-
gation (Figs. 3c, 3d).
the three most intense bands corresponding to 47, 120, 
and 200 kDa are readily detected in the extract and DeAe-
fraction (Figs. 3a, 3b). there are only a few known biotinylat-
ed proteins in yeast: Acc1p (250 kDa [31]), Hfa1p (242 kDa 
[32]), Pyc1p (130 kDa [33]), Pyc2p (130 kDa [33]), Dur1,2p (202 
kDa [34]), and Arc1p (42 kDa [35]). In general, the detected 
bands correspond to those described in the literature [35] and 
anticipated in accordance with the molecular masses of the 
known proteins.
In the case of the fractionation of telomerase enriched 
on DeAe-cellulose, one could see that biotinylated protein 
with an apparent molecular mass of 50 kDa comigrates and 
enriches with the telomerase complex. this is obvious from 
comparing Figs. 2c and 3c. In the case of S100 extract frac-
tionation, we could not find a correlation between the pres-
ence of telomerase activity and the presence of biotinylated 
protein, because a series of bands corresponding to all yeast 
biotinylated proteins were detected in all fractions like in the 
initial extract (data not shown).
We have shown that the yeast telomerase complex con-
tains biotinylated protein. We have not managed to establish 
what protein it is and what its function is. Our attempts to use 
MALDI-tOF analysis for identifying the protein of interest 
were unsuccessful due to a small amount of telomerase per 
cell (approximately 29 molecules of tLc1 rnA per haploid 
yeast cell [36]) and the fact that only a portion of the total 
amount of active telomerase contains biotinylated protein. 
Also, it should be noted that the elution of proteins bound on 
streptavidin-sepharose by the “biotin-streptavidin” inter-
action is a difficult task, because, due to the strength of the 
interaction, it is not quantitative [37].
It is obvious from Figs. 2c and 3c that the detected bioti-
nylated protein comigrates with the lighter portion of telom-
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Figure 1 . Isolation of yeast telomerase using chromatography on 
streptavidin-sepharose .  (a) Activity assay (elongation of oligodeoxyri-
bonucleotide TEL11) of telomerase isolated on streptavidin-sepharose 
from extract. RNase A(+) and RNase A(−) are the reactions with and 
without pretreatment with RNase A. (1, 2) the products of TEL11 
elongation by telomerase isolated on streptavidin-sepharose; (3, 4) 
the same for telomerase isolated on DEAE-cellulose. (b) The same as in 
(a) with pretreatment with and without avidin. Avidin(+) and Avidin(−) 
are the reactions with and without pretreatment with avidin. (1, 2) the 
same as (a; 1, 2).  (c) RT-PCR analysis of TLC1 RNA in samples obtained 
by telomerase isolation on streptavidin-sepharose with and without 
pretreatment with avidin. RT(−) and RT(+) are RT-PCR analyses without 
and with reverse transcription reaction. (1, 2) RT-PCR products obtained 
in an analysis of the initial extract (I); (3, 4) the same for unbound fraction 
(U); (5, 6) the same for bound fraction (B) without avidin pretreatment; 
(7) molecular weight marker; (8–13) the same as in (8–13) with avidin 
pretreatment. (d) Activity assay of telomerase isolated on streptavidin-
sepharose from DEAE-fraction. (1) 5’-[32P]- phosphorylated oligodeoxy-
nucleotide TEL11; (2) the products of TEL11 elongation by telomerase 
of initial DEAE-fraction (I); (3) the same for unbound fraction (U); (4) the 
same for bound fraction (B), taken in a 4-times excess84 | ActA nAturAe |  № 2 2009
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Figure 2 . Analysis of fractions obtained 
by ultracentrifugation in a glycerol 
density gradient (22 fractions from 
one gradient) . (a) Telomerase activity 
assay in fractions obtained by ultra-
centrifugation of S100 extract. (1–9) 
The products of TEL11 elongation by 
telomerase in fractions 1–9, respective-
ly. (b) RT-PCR analysis of TLC1 RNA in 
fractions obtained by ultracentrifugation 
of S100 extract. (1–9) RT-PCR products 
obtained in an analysis of fractions 1–22, 
respectively, two adjacent fractions in 
each lane (1) 1 and 2 fractions; (2) 3 and 
4 fractions, etc.). (c) The same as in (a) 
for fractions obtained by ultracentrifu-
gation of DEAE-fraction. (d) The same 
as in (b) for fractions obtained by the 
ultracentrifugation of DEAE-fraction
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Figure 3 . Western blotting analysis of biotinylated proteins in the initial S100 extract, DEAE-
fraction and fractions obtained by ultracentrifugation in glycerol density gradient . (a) 
Western blotting analysis of proteins in the initial S100 extract. (1–3) biotinylated proteins 
from extract (the amount of samples decreases from 1 to 3). (b) Western blotting analysis 
of proteins in DEAE-fraction. (1, 2) biotinylated proteins from DEAE-fraction in decreasing 
amounts (from 1 to 2). (c) Western blotting analysis of proteins in fractions obtained by 
the ultracentrifugation of DEAE-fraction. (1–8) biotinylated proteins from fractions 1–8, 
respectively; (9) biotinylated proteins from initial DEAE-fraction.  (d) The same as in (c) with 
the quick exposure of a membrane to a film
Figure 4 . Binding of heavy (2 and 3 fractions) and 
light (4 and 5 fractions) telomerase complexes 
obtained by S100 extract ultracentrifugation in 
glycerol gradient, with streptavidin-sepharose. 
RNase A(+) and RNase A(−) are the reactions with 
and without pretreatment with RNase A. (1, 2) 
the products of TEL11 elongation obtained by the 
telomerase of the initial heavy fraction (I); (3, 4) 
the same for bound fraction (B), taken in a 4-times 
excess and 10-times excess, respectively; (5–8) 
the same as in (1–4) for light fraction
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erase complexes. An interesting proposition could be made on 
the basis of this fact and the fact that biotinylated protein is 
present in less than half of the active telomerase complexes 
isolated on DeAe-cellulose. We speculated that the bioti-
nylated protein is a constituent of only the light telomerase 
complexes that may be in the maturation process but already 
active in vitro. We tested this idea for fractions obtained by 
the ultracentrifugation of the S100 extract. We combined two 
heavy fractions, and the same was done for two light frac-
tions. then, we performed the binding of these two samples 
with streptavidin–sepharose. In fact, one could see that the 
active telomerase from the heavy fractions does not bind to 
streptavidin-sepharose, while telomerase from light fractions 
binds (Fig. 4). So our proposition is proved, and this result dis-
proves the hypothesis that the biotinylated component dis-
sociates during purification on DeAe-cellulose, because, even 
without this purification step, only a portion of telomerase 
complexes contains biotinylated protein.
Our data (the molecular mass of a candidate protein is 
about 50 kDa) and the data existing in the literature al-
low us to speculate about the nature of biotinylated pro-
tein and its function. As was already noted, there are only 
a few known biotinylated proteins in yeast. these are three 
types of carboxylases containing biotin as a cofactor: acetyl-
coA carboxylases Acc1p (250 kDa [31]), Hfa1p (242 kDa 
[32]); piruvate carboxylases Pyc1p (130 kDa [33]), Pyc2p 
(130 kDa [33]); urea amidolyase Dur1,2p (202 kDa [34]; and 
protein Arc1p (42 kDa [35]), a cofactor of aminoacyl-trnA 
synthetase [38]. Arc1p is also known to bind quadruplex 
DnA [39]. Of these proteins, only Arc1p is the most similar 
in molecular mass to the discovered biotinylated protein. It 
is interesting that Arc1p does not contain a canonical se-
quence for biotinylation by biotin-protein ligase. Moreover, 
biotinylation is not functionally important for Arc1p activity 
[35]. As an rnA-binding protein and a protein that binds 
quadruplex DnA, Arc1p seems to be a possible candidate 
for the biotinylated component of telomerase. It is also pos-
sible that telomerase contains a protein that is not already 
known to be biotinylated, interacting as Arc1p with biotin 
ligase Bpl1p and as Arc1p without a canonical sequence for 
biotinylation.
An interesting question arises as to the role of biotinylat-
ed protein in the telomerase complex. We have found that 
only the lighter portion of telomerase complexes contains 
biotinylated protein. It is known that the main components 
of telomerase crucial for the elongation of telomeric DnA 
are telomerase reverse transcriptase est2p and telomerase 
rnA tLc1 [5]. Other components are necessary for regula-
tion, assembly, biogenesis and degradation of the complex [5]. 
Some of them join telomerase only transiently at a particu-
lar moment in a cell cycle. For example, proteins est1p and 
est3p, crucial for telomerase activity in vivo, become part of 
the complex only in the late S/G2 phase of the cell cycle [18]. 
Our data indicate that biotinylated protein is not a perma-
nent component of telomerase complex. It joins telomerase 
only transiently, on a particular step of assembly, biogenesis, 
regulation or degradation and probably participates in these 
processes.  
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